Fasting blood glucose is predictive of hypertension in a general Japanese population
暂无分享,去创建一个
M. Lanaspa | I. Hisatome | M. Kanbay | K. Niwa | Richard J. Johnson | M. Kuwabara | Ichiro Hisatome | Mehmet Kanbay | M. Ohno | C. Roncal-Jimenez | A. Andrés-Hernando | Miguel A. Lanaspa | Masanari Kuwabara | Yaswanth Chintaluru | Koichiro Niwa | Ana Andres-Hernando | Carlos Roncal-Jimenez | Minoru Ohno | Yaswanth Chintaluru | Carlos Roncal-Jimenez | Ana Andrés-Hernando | Yaswanth Chintaluru
[1] M. Lanaspa,et al. Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function , 2017, American Journal of Nephrology.
[2] Shah Ebrahim,et al. Fasting Blood Glucose and the Risk of Stroke and Myocardial Infarction , 2009, Circulation.
[3] P. Nilsson,et al. The metabolic syndrome: a glance at its history , 2006, Journal of hypertension.
[4] Taku Inoue,et al. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] R. Testa,et al. Glucose "peak" and glucose "spike": Impact on endothelial function and oxidative stress. , 2008, Diabetes research and clinical practice.
[6] M. Lanaspa,et al. Sugar, Uric Acid, and the Etiology of Diabetes and Obesity , 2013, Diabetes.
[7] L. Ferrucci,et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.
[8] A. Dominiczak,et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. , 2013, Journal of hypertension.
[9] David M. Reboussin,et al. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines , 2018, Hypertension.
[10] James O. Hill,et al. “Metabolically Healthy” Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes: 5‐year Japanese Cohort Study , 2017, Obesity.
[11] R. Touyz,et al. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. , 2015, The Canadian journal of cardiology.
[12] I. Hisatome,et al. Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension , 2014, Hypertension Research.
[13] M. Lanaspa,et al. Uric Acid in Hypertension and Renal Disease: The Chicken or the Egg , 2010, Blood Purification.
[14] Hyon K. Choi,et al. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. , 2011, Arthritis and rheumatism.
[15] B. Howard,et al. A Longitudinal Study of Hypertension Risk Factors and Their Relation to Cardiovascular Disease: The Strong Heart Study , 2006, Hypertension.
[16] M. Lanaspa,et al. Uric acid‐dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] G. Bernini,et al. The Inter-Relationship between Insulin Resistance and Hypertension , 2012, Drugs.
[18] G. Filippatos,et al. Effect of serum insulin on the association between hyperuricemia and incident heart failure. , 2010, The American journal of cardiology.
[19] H. Black,et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology. , 2015, Circulation.
[20] S. Kihara,et al. Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. , 2013, Journal of atherosclerosis and thrombosis.
[21] D. Adlam,et al. Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose , 2016, British journal of pharmacology.
[22] M. Lanaspa,et al. Uric acid and fructose: potential biological mechanisms. , 2011, Seminars in nephrology.
[23] S. Kihara,et al. The elderly. , 2014, Journal of atherosclerosis and thrombosis.
[24] T. Hayakawa,et al. Prevalence of hypertension, its awareness and control in adult population in Japan , 2004, Journal of Human Hypertension.
[25] K. Joshipura,et al. ASSOCIATION BETWEEN WITHIN-VISIT SYSTOLIC BLOOD PRESSURE VARIABILITY AND DEVELOPMENT OF PRE-DIABETES AND DIABETES AMONG OVERWEIGHT/OBESE INDIVIDUALS , 2017, Journal of Human Hypertension.
[26] M. Laakso,et al. High Serum Levels of Advanced Glycation End Products Predict Increased Coronary Heart Disease Mortality in Nondiabetic Women but not in Nondiabetic Men: A Population-Based 18-Year Follow-Up Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[27] D. Maahs,et al. Fructose and uric acid in diabetic nephropathy , 2015, Diabetologia.
[28] M. Lanaspa,et al. Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study , 2018, Hypertension.
[29] M. Lanaspa,et al. Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study , 2017, Hypertension.
[30] J. Meigs,et al. Hypertension and Diabetes Mellitus: Coprediction and Time Trajectories , 2018, Hypertension.
[31] C. Borghi,et al. Serum Uric Acid and Cardiometabolic Disease: Another Brick in the Wall? , 2017, Hypertension.
[32] J. Shaw,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[33] Yutaka Imai,et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014) , 2014, Hypertension Research.
[34] Yosikazu Nakamura,et al. Low frequency of toothbrushing practices is an independent risk factor for diabetes mellitus in male and dyslipidemia in female: A large-scale, 5-year cohort study in Japan. , 2017, Journal of cardiology.
[35] Maja O’Connor. LONGITUDINAL STUDY , 2013 .
[36] M. Lanaspa,et al. Uric acid in metabolic syndrome: From an innocent bystander to a central player. , 2016, European journal of internal medicine.
[37] M. Litwin,et al. Guidelines for the Management of Hypertension , 2015 .
[38] P. Chou,et al. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. , 2000, The Journal of rheumatology.
[39] M. Kuwabara. Hyperuricemia, Cardiovascular Disease, and Hypertension , 2016, Pulse.
[40] B. Djindjic,et al. The contributions of fasting and postprandial blood glucose increments to oxidative stress and inflammation in dyslipidemic type 2 diabetic patients with stable ischemic heart disease. , 2017, International journal of cardiology.
[41] B. Balkau,et al. Euglycemic Clamp Insulin Sensitivity and Longitudinal Systolic Blood Pressure: Role of Sex , 2013, Hypertension.
[42] M. Lanaspa,et al. Increased Serum Sodium and Serum Osmolarity Are Independent Risk Factors for Developing Chronic Kidney Disease; 5 Year Cohort Study , 2017, PloS one.
[43] S. Nitter‐Hauge,et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. , 1999, Diabetes care.
[44] P. Zimmet,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[45] Yaqin Yu,et al. Association of Blood Pressure with Fasting Blood Glucose Levels in Northeast China: A Cross-Sectional Study , 2018, Scientific Reports.
[46] Tobias Jung,et al. Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus , 2015, Biomolecules.